Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 195.40
Bid: 194.80
Ask: 195.60
Change: 2.40 (1.24%)
Spread: 0.80 (0.411%)
Open: 192.40
High: 195.60
Low: 192.00
Prev. Close: 193.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extended Product Claims for LiquiBand Exceed

3 Nov 2015 07:00

RNS Number : 3015E
Advanced Medical Solutions Grp PLC
03 November 2015
 

3 November 2015

Advanced Medical Solutions Group plc

("AMS" or the "Group")

 

FDA Approves Extended Product Claims for LiquiBand® Exceed™ Topical Skin Adhesive

 

Winsford, UK, 3 November 2015 - Advanced Medical Solutions Group plc (AIM: AMS.L), the surgical and advanced woundcare specialist company, today announced that the FDA has approved two new product claims for the octyl formulation product, LiquiBand Exceed™ giving it a competitive advantage in the topical skin adhesive market.

 

These claims will allow AMS and partners to differentiate LiquiBand Exceed™ around wound coverage, yield and reuse, providing clinicians with the ability to increase the usage of a single applicator, saving time and cost.

 

The two new claims include the use of a single device to cover wounds of up to 30cm, as well as a single device being suitable for intraoperative reuse for up to 90 minutes on a single patient. Both claims are unique FDA approved claims for the US Topical Skin Adhesive Market.

 

Following testing, LiquiBand® Exceed™ was found to deliver best in class yield to support coverage up to 30cm of wound length1, twice the amount advertised by market leading topical skin adhesive products2. Due to the proprietary LiquiBand Exceed™ formula, the adhesive polymerises via skin contact using naturally occurring skin moisture meaning that the applicator device does not dry out. In-vitro testing proved the device could continually express glue in intervals for up to 90 minutes after device activation.1

 

Chris Meredith, Chief Executive Officer of AMS, commented: "LiquiBand Exceed™ has been an excellent addition to our LiquiBand® topical skin adhesive portfolio demonstrating encouraging initial uptake since its launch this year. These extended US product claims will help us to continue to provide a superior product for clinicians and a versatile solution for healthcare providers in this key market, in which we are focused on growing our market share."

 

References:

1. Data on file at Advanced Medical Solutions (Plymouth) Ltd.

2. www.ethicon.com/healthcare-professionals/products/wound-closure/skin-adhesives/dermabond-advanced-topical-skin-adhesive#!description-and-specs

 

- Ends -

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Group Finance Director

Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Ivar Milligan

 

About Advanced Medical Solutions Group plc - see www.admedsol.com 

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in 65 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 470 employees. For more information please see www.admedsol.com.

About LiquiBand® Exceed™

The LiquiBand® portfolio of topical skin adhesives have been developed to provide the global medical market with innovative wound closure products. The LiquiBand® devices have been uniquely designed to meet the needs of clinicians and patients for safe, secure and effective topical wound closure.

LiquiBand® Exceed™ is the newest and most innovative topical skin adhesive to join the LiquiBand® family of products. LIQUIBAND Exceed™ is a 2-octyl cyanoacrylate adhesive that has a unique felt applicator tip to facilitate even, consistent application. The pure octyl formulation maximizes durability and flexibility while providing high viscosity. LiquiBand® Exceed™ provides an effective microbial barrier to gram positive, gram negative and fungal microbes. The porous felt applicator tip creates even, consistent application while also preventing squirting and dripping of adhesive. The tip has an elliptical shape to allow for versatility in application technique and can provide wide or narrow application strips.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALFFELLSLFIIE
Date   Source Headline
1st May 20249:10 amRNSTotal Voting Rights
26th Apr 20249:17 amRNSDirector/PDMR Shareholding
25th Apr 20243:41 pmRNSHolding(s) in Company
17th Apr 20243:30 pmRNSHolding(s) in Company
4th Apr 20243:17 pmRNSHolding(s) in Company
2nd Apr 20242:47 pmRNSDirector/PDMR and PCA Shareholding
28th Mar 20245:04 pmRNSTotal Voting Rights
18th Mar 202412:35 pmRNSDirector/PDMR Shareholding
13th Mar 20247:03 amRNSProposed acquisition of Peters Surgical
13th Mar 20247:03 amRNSUnaudited Preliminary Results
12th Mar 20247:00 amRNSBlock listing Interim Review
10th Jan 20247:00 amRNSFull Year Trading Update
30th Nov 20235:11 pmRNSTotal Voting Rights
31st Oct 20235:02 pmRNSTotal Voting Rights
25th Oct 20237:00 amRNSUS LiquiBand® distribution agreements signed
2nd Oct 20237:01 amRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSAppointment of New Chair
27th Sep 20235:55 pmRNSDirector/PDMR Shareholding
25th Sep 20233:15 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSLiquiBand Fix8® US commercialisation agreement
14th Sep 20233:52 pmRNSBlock listing Interim Review
4th Sep 20237:00 amRNSTrading Statement
31st Aug 20235:56 pmRNSTotal Voting Rights
10th Aug 20237:00 amRNSNotice of Interim Results
31st Jul 20234:51 pmRNSTotal Voting Rights
11th Jul 20237:00 amRNSHalf Year Trading Update
30th Jun 20232:14 pmRNSTotal Voting Rights
19th Jun 202312:18 pmRNSStandard form for notification of major holdings
5th Jun 20237:00 amRNSUS regulatory approval granted for LiquiBandFix8®
31st May 20232:08 pmRNSResults of Annual General Meeting
31st May 20237:00 amRNSAnnual General Meeting
22nd May 20236:13 pmRNSDirector/PDMR Shareholding
28th Apr 20235:57 pmRNSTotal Voting Rights
26th Apr 20235:37 pmRNSAnnual Report and Notice of Annual General Meeting
18th Apr 20236:22 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:41 pmRNSTotal Voting Rights
27th Mar 20235:56 pmRNSDirector/PDMR and PCA Shareholding
22nd Mar 20235:52 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSUnaudited Preliminary Results
8th Mar 20232:56 pmRNSBlock listing announcement
28th Feb 20235:56 pmRNSTotal Voting Rights
14th Feb 20237:01 amRNSNotice of Results
1st Feb 20231:30 pmRNSAcquisition of Connexicon Medical
31st Jan 20233:17 pmRNSTotal Voting Rights
10th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSTotal Voting Rights
30th Nov 20226:04 pmRNSTotal Voting Rights
28th Nov 20224:20 pmRNSChange of Registrar
31st Oct 20227:00 amRNSLiquiBandFix8® PMA application accepted by FDA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.